• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors" [Bioorg. Med. Chem. Lett. 53 (2021) 128409].

作者信息

Li Pei, Cai Shi, Zhao Tong, Xu Lin, Guan Dezhong, Li Jinruo, Zhou Jinpei, Zhang Huibin

机构信息

Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

Center of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

出版信息

Bioorg Med Chem Lett. 2022 Jan 15;56:128502. doi: 10.1016/j.bmcl.2021.128502. Epub 2021 Dec 11.

DOI:10.1016/j.bmcl.2021.128502
PMID:34906405
Abstract
摘要

相似文献

1
Corrigendum to "Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors" [Bioorg. Med. Chem. Lett. 53 (2021) 128409].《作为TRK抑制剂的大环衍生物的设计、合成及生物学评价》的勘误[《生物有机与药物化学快报》53 (2021) 128409]
Bioorg Med Chem Lett. 2022 Jan 15;56:128502. doi: 10.1016/j.bmcl.2021.128502. Epub 2021 Dec 11.
2
Corrigendum to "Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives" [Bioorg Med Chem Lett 27(16) (2017) 3920-3924].
Bioorg Med Chem Lett. 2019 Feb 1;29(3):515. doi: 10.1016/j.bmcl.2018.11.012. Epub 2018 Dec 19.
3
Corrigendum to "Design, synthesis and biological evaluation of novel procaine derivatives for intravenous anesthesia" [Bioorg. Med. Chem. Lett. 60 (2022) 128587].《新型用于静脉麻醉的普鲁卡因衍生物的设计、合成及生物学评价》的勘误 [《生物有机与药物化学快报》60 (2022) 128587]
Bioorg Med Chem Lett. 2022 Jul 15;68:128765. doi: 10.1016/j.bmcl.2022.128765. Epub 2022 May 4.
4
Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].《查耳酮衍生物作为抗炎剂的设计、合成、生物学评价及分子对接》的勘误 [《生物有机与药物化学快报》27 (3) (2017) 602 - 606]
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3822. doi: 10.1016/j.bmcl.2018.10.027. Epub 2018 Oct 30.
5
Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].《新型苯甲酰胺衍生物作为高效的Smoothened拮抗剂的合成及生物学评价》的勘误[《生物有机与药物化学快报》24/5 (2014) 1426 - 1431]
Bioorg Med Chem Lett. 2016 Sep 15;26(18):4558. doi: 10.1016/j.bmcl.2015.06.051. Epub 2016 Aug 16.
6
Corrigendum to "Identification of 2-substituted pyrrolo[1,2-b]pyridazine derivatives as new PARP-1 inhibitors" [Bioorg. Med. Chem. Lett. 31 (2021) 127710].对“鉴定2-取代吡咯并[1,2-b]哒嗪衍生物作为新型PARP-1抑制剂”[《生物有机与药物化学快报》31 (2021) 127710]的勘误
Bioorg Med Chem Lett. 2022 Jan 15;56:128501. doi: 10.1016/j.bmcl.2021.128501. Epub 2021 Dec 12.
7
Corrigendum to 'Easy and rapid preparation of benzoylhydrazides and their diazene derivatives as inhibitors of 15-lipoxygenase' [Bioorg. Med. Chem. Lett. 27 (2017) 1649-1653].
Bioorg Med Chem Lett. 2017 Sep 1;27(17):4218. doi: 10.1016/j.bmcl.2017.07.065. Epub 2017 Aug 2.
8
Corrigendum to "Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5 [Bioorg Med Chem Lett 28 (17) (2018) 2930-2938]".《新型噻二唑 - 噻唑啉酮杂化物作为人有丝分裂驱动蛋白Eg5潜在抑制剂的设计与合成》勘误 [《生物有机与药物化学快报》28 (17) (2018) 2930 - 2938]
Bioorg Med Chem Lett. 2018 Nov 15;28(21):3489. doi: 10.1016/j.bmcl.2018.08.029. Epub 2018 Sep 29.
9
Corrigendum to "Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors" [Bioorg. Med. Chem. Lett. 24 (2014) 5093-5097].
Bioorg Med Chem Lett. 2017 Jul 15;27(14):3205. doi: 10.1016/j.bmcl.2017.05.056. Epub 2017 May 24.
10
Corrigendum to "A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484].《新型他克林-吡喃并吡唑衍生物的级联合成、体外胆碱酯酶抑制活性及对接研究》的勘误[《生物有机与药物化学快报》28(14)(2018)2481 - 2484]
Bioorg Med Chem Lett. 2018 Oct 1;28(18):3129. doi: 10.1016/j.bmcl.2018.08.008. Epub 2018 Aug 14.